Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James H Feusner

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Pediatric Hematology/Oncology|June 20, 2014
Therapy-induced secondary acute myeloid leukemia with t(11;19)(q23;p13.1) in a pediatric patient with relapsed acute promyelocytic leukemiaDaniel N Dang, Heather D Morris, James H Feusner, et al.
Journal of Pediatric Hematology/Oncology|August 11, 2018
Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631Madhvi Rajpurkar, Todd A Alonzo, Yi-Cheng Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2013
Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: a report from the children's oncology groupKimberly J Johnson, Katherine S Williams, Julie A Ross, et al.
Pediatric Blood & Cancer|November 6, 2018
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)Matthew A Kutny, Susan Geyer, Kristina M Laumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
The Minneapolis-Manchester Quality of Life instrument: reliability and validity of the Adolescent FormSmita Bhatia, Meriel E M Jenney, Monica K Bogue, et al.
The Journal of Pediatrics|July 9, 2004
The Minneapolis-Manchester Quality of Life instrument: Reliability and validity of the Youth FormSmita Bhatia, Meriel E M Jenney, Eric Wu, et al.
Pediatric Nephrology (Berlin, Germany)|March 21, 2012
Treatments and outcomes for end-stage renal disease following Wilms tumorYevgeny Grigoriev, Jane Lange, Susan M Peterson, et al.
British Journal of Haematology|September 22, 2016
Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panelOussama Abla, Matthew A Kutny, Anna Maria Testi, et al.
Pediatric Blood & Cancer|July 22, 2014
Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology GroupLucie M Turcotte, Michael K Georgieff, Julie A Ross, et al.
Pediatric Blood & Cancer|June 27, 2013
Outcomes for patients with congenital hepatoblastomaAngela D Trobaugh-Lotrario, Barbara H Chaiyachati, Rebecka L Meyers, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Pediatric Hematology/Oncology|June 20, 2014
Therapy-induced secondary acute myeloid leukemia with t(11;19)(q23;p13.1) in a pediatric patient with relapsed acute promyelocytic leukemiaDaniel N Dang, Heather D Morris, James H Feusner, et al.
Journal of Pediatric Hematology/Oncology|August 11, 2018
Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631Madhvi Rajpurkar, Todd A Alonzo, Yi-Cheng Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2013
Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: a report from the children's oncology groupKimberly J Johnson, Katherine S Williams, Julie A Ross, et al.
Pediatric Blood & Cancer|November 6, 2018
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance)Matthew A Kutny, Susan Geyer, Kristina M Laumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
The Minneapolis-Manchester Quality of Life instrument: reliability and validity of the Adolescent FormSmita Bhatia, Meriel E M Jenney, Monica K Bogue, et al.
The Journal of Pediatrics|July 9, 2004
The Minneapolis-Manchester Quality of Life instrument: Reliability and validity of the Youth FormSmita Bhatia, Meriel E M Jenney, Eric Wu, et al.
Pediatric Nephrology (Berlin, Germany)|March 21, 2012
Treatments and outcomes for end-stage renal disease following Wilms tumorYevgeny Grigoriev, Jane Lange, Susan M Peterson, et al.
British Journal of Haematology|September 22, 2016
Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panelOussama Abla, Matthew A Kutny, Anna Maria Testi, et al.
Pediatric Blood & Cancer|July 22, 2014
Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology GroupLucie M Turcotte, Michael K Georgieff, Julie A Ross, et al.
Pediatric Blood & Cancer|June 27, 2013
Outcomes for patients with congenital hepatoblastomaAngela D Trobaugh-Lotrario, Barbara H Chaiyachati, Rebecka L Meyers, et al.
Pageof 6